High Immunogenicity to Influenza Vaccination in Crohn’s Disease Patients Treated with Ustekinumab

Influenza vaccination can be less effective in patients treated with immunosuppressive therapy. However, little is known about the effects of ustekinumab; an anti-IL-12/23 agent used to treat Crohn’s disease (CD), on vaccination response. In this prospective study, we assessed immune responses to se...

Полное описание

Библиографические подробности

Главные авторы:	Laura Doornekamp, Rogier L. Goetgebuer, Katharina S. Schmitz, Marco Goeijenbier, C. Janneke van der Woude, Ron Fouchier, Eric C.M. van Gorp, Annemarie C. de Vries
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2020-08-01
Серии:	Vaccines
Предметы:	ustekinumab influenza vaccine Crohn’s disease
Online-ссылка:	https://www.mdpi.com/2076-393X/8/3/455
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!